Drug intelligence / Profile preview

Optive + Systane

Development stage
Unknown
Lead developer
Allergan
Modality
Small Molecules
Administration
Ophthalmic
01

Overview

Optive + Systane is a non-standard combination referring to the concurrent or sequential use of two over-the-counter artificial tear products, "Optive" (by Allergan) and "Systane" (by Alcon), both designed for the relief of dry eye symptoms. These are not co-formulated in a single product but are sometimes used together by patients seeking combined benefits from their different ingredient profiles. - **Optive** products typically contain carboxymethylcellulose sodium as a lubricant, along with osmoprotectants such as L-carnitine and erythritol, which help protect corneal epithelial cells from hyperosmolar stress[8]. - **Systane** products (such as Systane Ultra or Systane Balance) use polyethylene glycol and/or propylene glycol as lubricants, with hydroxypropyl guar acting as a gelling agent to increase retention time on the ocular surface[1][4][5]. Some formulations also include mineral oil or phospholipids for lipid layer support[7]. Both brands act primarily by supplementing the tear film to relieve dryness and irritation; they do not have pharmacological activity beyond lubrication and osmoprotection.

Brand names
Optive + Systane
Other names
Systane + Optive
02

Targets

MUC (Mucin family)

Beyond the preview

Go deeper on Optive + Systane.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Optive + Systane.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call